Follow
Thomas Evangelidis
Thomas Evangelidis
AI|ffinity
Verified email at aiffinity.com - Homepage
Title
Cited by
Cited by
Year
Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir
L Xie, T Evangelidis, L Xie, PE Bourne
PLoS computational biology 7 (4), e1002037, 2011
1872011
De novo design of a non-local β-sheet protein with high stability and accuracy
E Marcos, TM Chidyausiku, AC McShan, T Evangelidis, S Nerli, L Carter, ...
Nature structural & molecular biology 25 (11), 1028-1034, 2018
1152018
Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant
P Gkeka, T Evangelidis, M Pavlaki, V Lazani, S Christoforidis, B Agianian, ...
PLoS computational biology 10 (10), e1003895, 2014
962014
Origin, diversification and substrate specificity in the family of NCS 1/FUR transporters
E Krypotou, T Evangelidis, J Bobonis, AA Pittis, T Gabaldón, ...
Molecular microbiology 96 (5), 927-950, 2015
682015
Automated NMR resonance assignments and structure determination using a minimal set of 4D spectra
T Evangelidis, S Nerli, J Nováček, AE Brereton, PA Karplus, RR Dotas, ...
Nature communications 9 (1), 384, 2018
432018
Modelling, substrate docking and mutational analysis identify residues essential for function and specificity of the major fungal purine transporter AzgA
E Krypotou, G Lambrinidis, T Evangelidis, E Mikros, G Diallinas
Molecular Microbiology 93 (1), 129-145, 2014
332014
Distinct EH domains of the endocytic TPLATE complex confer lipid and protein binding
K Yperman, AC Papageorgiou, R Merceron, S De Munck, Y Bloch, ...
Nature communications 12 (1), 3050, 2021
262021
The Aspergillus nidulans proline permease as a model for understanding the factors determining substrate binding and specificity of fungal amino acid transporters
C Gournas, T Evangelidis, A Athanasopoulos, E Mikros, ...
Journal of Biological Chemistry 290 (10), 6141-6155, 2015
262015
Insight on specificity of uracil permeases of the NAT/NCS2 family from analysis of the transporter encoded in the pyrimidine utilization operon of Escherichia coli
M Botou, P Lazou, K Papakostas, G Lambrinidis, T Evangelidis, E Mikros, ...
Molecular Microbiology 108 (2), 204-219, 2018
192018
An integrated workflow for proteome-wide off-target identification and polypharmacology drug design
T Evangelidis, L Xie
Tsinghua Science and Technology 19 (3), 275-284, 2014
62014
Discovery of new aminosubstituted pyrrolopyrimidines with antiproliferative activity against breast cancer cells and investigation of their effect towards the PI3Kα enzyme
K Daniilides, N Lougiakis, T Evangelidis, IK Kostakis, N Pouli, P Marakos, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017
32017
Structural basis for the mechanism and antagonism of receptor signaling mediated by Interleukin-9 (IL-9)
T De Vos, M Godar, F Bick, AC Papageorgiou, T Evangelidis, I Marković, ...
bioRxiv, 2022.12. 30.522308, 2022
2022
4D-CHAINS
T Evangelidis, K Tripsianes
2021
4D-GRAPHS
T Brázdil, D Porteš, J Filipovič, J Hozzová, T Evangelidis, K Tripsianes
2021
Structural studies of the oncoproteins c-Myc and PI3Kα and development of new synthetic molecules inhibiting their function
T Evangelidis
Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Σχολή Επιστημών Υγείας …, 2017
2017
Structure-function analysis of the different selectivity preferences of pyrimidine and/or purine transporters in the Nucleobase: Cation Symporter-2 (NCS2) family
M Botou, K Papakostas, T Evangelidis, E Mikros, S Frillingos
FEBS JOURNAL 282, 11-11, 2015
2015
The Aspergillus nidulans Proline Permease as a Model for Understanding the Factors Determining Substrate Binding and Specificity of Fungal Amino Acid Transporters
T Evangelidis, A Athanasopoulos, E Mikros, V Sophianopoulou
2015
Substrate binding and specificity of fungal aa transporters
C Gournas, T Evangelidis, A Athanasopoulos, E Mikros, ...
regulation 12, 14, 2015
2015
Allosteric Modulation of WT and H1047R Mutant PI3Kα Investigated by MD Simulations
P Gkeka, T Evangelidis, Z Cournia
Biophysical Journal 104 (2), 402a, 2013
2013
MD simulations of the PI3K alpha wild type and mutant forms: Implications for drug design
T Evangelidis, P Gkeka, Z Cournia
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 243, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20